Ionis Pharmaceuticals
(IONS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -60,400 | -112,421 | -119,772 | -62,917 | -88,278 |
| Depreciation Amortization | 47,654 | 35,743 | 23,938 | 12,022 | 47,923 |
| Accounts receivable | -96,687 | 2,812 | 10,610 | -5,124 | -7,453 |
| Accounts payable and accrued liabilities | -10,677 | -15,200 | -12,436 | -11,417 | 9,211 |
| Other Working Capital | -177,747 | -66,672 | -53,546 | -45,372 | 20,496 |
| Other Operating Activity | 185,752 | 70,472 | 41,654 | 37,040 | 39,226 |
| Operating Cash Flow | $-112,105 | $-85,266 | $-109,552 | $-75,768 | $21,125 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 63,660 | 43,485 | 98,344 | 40,439 | -73,883 |
| PPE Investments | -7,107 | -4,313 | -3,263 | -628 | -7,692 |
| Sale Of Investment | 4,467 | 0 | N/A | N/A | 25,579 |
| Purchase Sale Intangibles | -4,421 | -3,374 | -2,195 | -382 | -4,056 |
| Other Investing Activity | -4,421 | -3,374 | -2,195 | -382 | -4,056 |
| Investing Cash Flow | $56,599 | $35,798 | $92,886 | $39,429 | $-60,052 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,000 | 4,000 | N/A | N/A | 8,500 |
| Debt Repayment | -7,066 | -5,428 | -3,717 | -1,857 | -9,058 |
| Common Stock Issued | 13,417 | 7,254 | 4,120 | 2,736 | 24,888 |
| Other Financing Activity | 1,043 | -880 | 0 | 0 | 396 |
| Financing Cash Flow | $11,394 | $4,946 | $403 | $879 | $24,726 |
| Beginning Cash Position | 128,797 | 128,797 | 128,797 | 128,797 | 142,998 |
| End Cash Position | 84,685 | 84,275 | 112,534 | 93,337 | 128,797 |
| Net Cash Flow | $-44,112 | $-44,522 | $-16,263 | $-35,460 | $-14,201 |
| Free Cash Flow | |||||
| Operating Cash Flow | -112,105 | -85,266 | -109,552 | -75,768 | 21,125 |
| Capital Expenditure | -7,107 | -4,313 | -3,263 | -628 | -7,692 |
| Free Cash Flow | -119,212 | -89,579 | -112,815 | -76,396 | 13,433 |